LSE:SHEL
LSE:SHELOil and Gas

Shell (LSE:SHEL) Reports Q2 2025 Earnings With US$3,601 Million Net Income

Shell (LSE:SHEL) recently announced its Q2 2025 performance, with net income rising slightly to USD 3,601 million despite a decrease in sales and revenue compared to the previous year. Alongside, the company maintained a consistent interim dividend, which could reinforce investor confidence. Over the last quarter, the company's share price increased by 9.95%, seemingly aligned with the broader market trend, where major indexes posted gains. The corporate guidance updates for Q3 could also...
LSE:AZN
LSE:AZNPharmaceuticals

AstraZeneca (LSE:AZN) Advances Lung Cancer Care With Revna Biosciences In Ghana

AstraZeneca (LSE:AZN) marked progress in its collaboration with Revna Biosciences, focusing on lung cancer care in Ghana, which includes launching targeted therapies and enhancing oncology treatment capacity. Despite this positive development, the stock's 13% rise last month aligns more closely with broader market dynamics, supported by solid earnings and a dividend increase. These factors added positive momentum as the S&P 500 and Nasdaq achieved record highs, driven by robust tech sector...
AIM:AREC
AIM:ARECBiotechs

Arecor Therapeutics And 2 Other UK Penny Stocks To Consider

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid concerns over China's economic recovery and its impact on global trade. Despite these broader market pressures, investors often seek opportunities in less conventional areas like penny stocks, which can offer unique prospects for growth. While the term "penny stock" may seem outdated, it still signifies a space where smaller or newer companies with robust financials can provide...